Freshfields advises life sciences clients across biopharma, medical devices, digital health, and health IT on strategic transactions and contentious matters. Kristen Riemenschneider heads the team from Washington DC. Adam Golden and Vinita Kailasanath have departed the firm.
Legal 500 Editorial commentary
Key clients
- Acelyrin
- AstraZeneca
- Basilea
- Camurus
- CK Life Sciences
- Cullinan Therapeutics
- Johnson & Johnson
- Merck
- Novartis
- Sanofi
- SERB Pharmaceuticals
- Standard BioTools Inc.
Work highlights
Advised Merck on its $10bn acquisition of Verona plc.
Advised Sanofi on its acquisition of Vigil Neurosciences.
Advised Novartis on its strategic collaboration with Monte Rosa Therapeutics regarding the development of novel degraders for immune-mediated diseases.
Practice head
Kristen Riemenschneider